Exenatide use in islet transplantation: Words of caution

Transplantation

Volumn 87, Issue 1, 2009, Pages 153-

  Rickels, Michael R ^a   Naji, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; INSULIN; PEPTIDE; VENOM;

ADJUVANT THERAPY; CLINICAL TRIAL; DRUG USE; GRAFT DYSFUNCTION; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; LETTER; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; DRUG EFFECT; GRAFT SURVIVAL; NOTE; REPRODUCIBILITY; TIME;

GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PEPTIDES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VENOMS;

EID: 58949091296     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318191eb48     Document Type: Letter

References (9)

1. Froud T, Faradji RN, Pileggi A, et al. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: Safety, efficacy, and metabolic effects. Transplantation 2008; 86: 36.
2. Al Ghofaili K, Fung M, Ao ZL, et al. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation 2007; 83: 24.
3. Rickels MR, Schutta MH, Mueller R, et al. Islet cell hormonal responses to hypogly-cemia after human islet transplantation for type 1 diabetes. Diabetes 2005; 54: 3205.
4. Gebhard B, Holst JJ, Biegelmayer C, et al. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 2001; 46: 1915.
5. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678.
6. Todd JF, Stanley SA, Roufosse CA, et al. A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet 2003; 361: 228.
7. Gangemi A, Salehi P, Hatipoglu B, et al. Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol. Am J Transplant 2008; 8: 1.
8. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741.
9. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. J Am Med Assoc 2005; 293: 830.